Overview

rs909706 is a genetic variant.

This variant is located on chromosome 6. The variations at position 15660640 are the genetic letters C/C, T/T, C/T

Since humans have each twice (one from each parent), these letter-variations occur on both chromosomes. People can have the same or different letters on both chromosomes. Every person's individual variation combination is referred to as genotype. For variant rs909706 there are 3 currently known genotypes : C/C, T/T or C/T

Short Overview

Variant Location

rs909706 is located on gene in chromsome 6. Use the genome browser to explore the location of rs909706 and its genetic neighbourhood.

Conditions & Traits

rs909706 affects the following conditions and traits:

There are currently 0 conditions and 0 traits associated with rs909706.

Pathogenicity

rs909706 affects the following conditions:

There are currently 0 conditions associated with rs909706.

Pharmacogenetics

rs909706 affects the following drugs:

Genome Browser

This interactive browser visualizes what no human can see with the naked eye - our DNA. From a down to a specific position on a . The position you are looking at here is the exact location of variant rs. Explore more variants and their effects on the body by browsing left and right along the DNA strand.

Loading Genome Browser...

Did you know genetic variants affect drugs?

Mutations are changes in genes and genetic variations are differences in the DNA among people. Variants are tiny changes in just one piece of the DNA while haplotypes are groups of these changes that usually come together.

Dr. Wallerstorfer Dr. Wallerstorfer

Conditions & Traits of rs909706

Current research shows 0 conditions and 0 traits.

Conditions

0

Pharmacogenetics

The genetic variant rs909706 impacts how certain medications work in the body. This difference may cause some of us to require different dosage amounts to achieve the desired effects, while others might experience more apparent side-effects. As a result, healthcare providers may need to adjust prescriptions for those individuals with rs909706. Ultimately, understanding our genetic makeup helps improve the overall effectiveness and usability of medications. Tailoring treatments based on genetics ensures a safer, more personalized healthcare experience.

Genotype
Level of evidence
Impacts
Summary
CC

Breakdown

Drug Effect

Side Effects

Dosage

Individuals with the genotype C/C have decreased Drug Effect to HALOPERIDOL.

more info

CT

Breakdown

Drug Effect

Side Effects

Dosage

Individuals with the genotype C/T have increased Drug Effect to HALOPERIDOL.

more info

TT

Breakdown

Drug Effect

Side Effects

Dosage

Individuals with the genotype T/T have increased Drug Effect to HALOPERIDOL.

more info

Legend:

Increased

Decreased

No known effect

Genotype
CC
Impacts

Breakdown

Drug Effect

Side Effects

Dosage

Summary

Individuals with the genotype C/C have decreased Drug Effect to HALOPERIDOL.

Level of evidence

More info

Genotype
CT
Impacts

Breakdown

Drug Effect

Side Effects

Dosage

Summary

Individuals with the genotype C/T have increased Drug Effect to HALOPERIDOL.

Level of evidence

More info

Genotype
TT
Impacts

Breakdown

Drug Effect

Side Effects

Dosage

Summary

Individuals with the genotype T/T have increased Drug Effect to HALOPERIDOL.

Level of evidence

More info

Legend:

Increased

Decreased

No known effect

Drugs related to rs909706

All drugs that are linked to rs909706 are listed here.

Studies and Sources

All of the resources below examine variant rs909706

Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants (9/29/10)

Ramón Cacabelos, Lucía Fernández-Novoa, Rocío Martínez-Bouza, Adam McKay, Juan C. Carril, Valter Lombardi, Lola Corzo, Iván Carrera, Iván Tellado, Laura Nebril, Margarita Alcaraz, Susana Rodríguez, Ángela Casas, Verónica Couceiro, Antón Álvarez

PMC: 4034082
Biological Predictors of Clozapine Response: A Systematic Review (7/26/18)

Ruta Samanaite, Amy Gillespie, Kyra-Verena Sendt, Grant McQueen, James H. MacCabe, Alice Egerton

PMC: 6070624
A review of clinical pharmacogenetics Studies in African populations (4/27/21)

Fouzia Radouani, Lyndon Zass, Yosr Hamdi, Jorge da Rocha, Reem Sallam, Sonia Abdelhak, Samah Ahmed, Maryame Azzouzi, Ichrak Benamri, Alia Benkahla, Balkiss Bouhaouala-Zahar, Melek Chaouch, Haifa Jmel, Rym Kefi, Ayoub Ksouri, Judit Kumuthini, Phumlani Masilela, Collen Masimirembwa, Houcemeddine Othman, Sumir Panji, Lilia Romdhane, Chaimae Samtal, Rania Sibira, Kais Ghedira, Faisal Fadlelmola, Samar Kamal Kassim, Nicola Mulder

PMC: 8093600
DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved